1 minute reading time (92 words)

Interleukin-10 Resolves Pain Hypersensitivity Induced by Cisplatin by Reversing Sensory Neuron Hyperexcitability

Understanding the mechanisms that drive transition from acute to chronic pain is essential to identify new therapeutic targets. The importance of endogenous resolution pathways acting as a "brake" to prevent development of chronic pain has been largely ignored. We examined the role of IL-10 in resolution of neuropathic pain induced by cisplatin. In search of an underlying mechanism, we studied the effect of cisplatin and IL-10 on spontaneous activity (SA) in DRG neurons. Cisplatin (2 mg/kg daily for 3 days) induced mechanical hypersensitivity that resolved within 3 weeks.

Read the abstract. 

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More